Assenagon Asset Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $371K | Hold |
|
|||||
|
2025
Q2 | $331K | Sell |
|
|||||
|
2025
Q1 | $367K | Buy |
|
|||||
|
2024
Q4 | $527K | Sell |
|
|||||
|
2024
Q3 | $33.6M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $2.44M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $92.4K | Hold |
|
|||||
|
2022
Q4 | $143K | Hold |
|
|||||
|
2022
Q3 | $168K | Sell |
|
|||||
|
2022
Q2 | $325K | Buy |
|
|||||
|
2022
Q1 | $1.2M | Buy |
|
|||||
|
2021
Q4 | $1.98M | Buy |
|
|||||
|
2021
Q3 | $2.12M | Sell |
|
|||||
|
2021
Q2 | $1.96M | Buy |
|
|||||
|
2021
Q1 | $1.17M | Sell |
|
|||||
|
2020
Q4 | $1.27M | Buy |
|
|||||
|
2020
Q3 | $860K | Sell |
|
|||||
|
2020
Q2 | $3.08M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $98K | Sell |
|
|||||
|
2019
Q2 | $1.42M | Buy |
|
|||||
|
2019
Q1 | $757K | Buy |
|